{"entity":{"type":"insider","cik":"0001880600","url":"/insider/0001880600","json_url":"/insider/0001880600.json","name":"Boyle Kevin S. Sr.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":2,"first":"2021-11-17","last":"2023-09-05","span_basis":"filed_date"},"name_variants":[{"name":"Boyle Kevin S. Sr.","source":"filing","n_filings":2,"first_seen":"2021-11-17","last_seen":"2023-09-05"}],"transactions":[{"id":8040178,"accession":"0000950170-23-046504","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-046504","line_url":"/filing/0000950170-23-046504#line-1","is_derivative":false,"issuer_cik":"0001107421","issuer_name":"Alaunos Therapeutics, Inc.","issuer_ticker":"TCRT","issuer_name_source":null,"issuer_url":"/issuer/0001107421","owner_cik":"0001880600","owner_name":"Boyle Kevin S. Sr.","owner_display_name":"Boyle Kevin S. Sr.","owner_url":"/insider/0001880600","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":68014.0,"shares_display":"68,014","price_per_share":0.1403,"price_display":"0.14","price_state":"stated","total_value":9542.3642,"total_display":"9,542.36","total_whole":"9,542","shares_owned_after":798236.0,"shares_owned_after_display":"798,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-01","filed_date":"2023-09-05","scope":"insider"},{"id":5299782,"accession":"0001209191-21-065138","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-065138","line_url":"/filing/0001209191-21-065138#line-2","is_derivative":false,"issuer_cik":"0001107421","issuer_name":"ZIOPHARM ONCOLOGY INC","issuer_ticker":"ZIOP","issuer_name_source":null,"issuer_url":"/issuer/0001107421","owner_cik":"0001880600","owner_name":"Boyle Kevin S. Sr.","owner_display_name":"Boyle Kevin S. Sr.","owner_url":"/insider/0001880600","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9116.0,"shares_display":"9,116","price_per_share":1.4,"price_display":"1.40","price_state":"stated","total_value":12762.4,"total_display":"12,762.40","total_whole":"12,762","shares_owned_after":885000.0,"shares_owned_after_display":"885,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-17","filed_date":"2021-11-17","scope":"insider"},{"id":5299778,"accession":"0001209191-21-065138","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-065138","line_url":"/filing/0001209191-21-065138#line-1","is_derivative":false,"issuer_cik":"0001107421","issuer_name":"ZIOPHARM ONCOLOGY INC","issuer_ticker":"ZIOP","issuer_name_source":null,"issuer_url":"/issuer/0001107421","owner_cik":"0001880600","owner_name":"Boyle Kevin S. Sr.","owner_display_name":"Boyle Kevin S. Sr.","owner_url":"/insider/0001880600","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":884.0,"shares_display":"884","price_per_share":1.4,"price_display":"1.40","price_state":"stated","total_value":1237.6,"total_display":"1,237.60","total_whole":"1,238","shares_owned_after":875884.0,"shares_owned_after_display":"875,884","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-16","filed_date":"2021-11-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001107421","name":"Alaunos Therapeutics, Inc.","url":"/issuer/0001107421","role":"Director, Officer (Chief Executive Officer)","n_filings":2,"first_seen":"2021-11-17","last_seen":"2023-09-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001880600","retrieved_at":"2026-08-22T16:53:41+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}